Special Drug Use-results Survey for Long-term Use (Fostamatinib) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Special Drug Use-results Survey for Long-term Use (Fostamatinib) — Stella

Recruiting

Back to Chronic Idiopathic Thrombocytopenic Purpura trials

Trial locations(1 site)

Japan

Research site, Tokyo and Japanese Other Cities

Key details

Sponsor

Kissei Pharmaceutical Co., Ltd.

Enrollment target

~149 participants

Started

May 2023

Primary completion

September 2028

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov